James F. Howard, MD, Distinguished Professor of Neuromuscular Disease, Professor of Neurology, Medicine and Allied Health at the UNC School of Medicine, was the lead investigator of the clinical trial. James F. Howard, Jr., MD UCB, a global biopharmaceutical company, announced on October 17th that ZILBRYSQ® (zilucoplan) has been approved by the U.S. Food and Drug … Read more